Solentim awarded ISO 9001 certification

Benchmarking best practice management in design, assembly and supply of Cell Metric™ cell line development equipment

 

ISO 9001 certification

(ISO 9001: 2008 certification - for a high resolution image, please email [email protected])

Bournemouth, UK (BUSINESS WIRE) – 9th February 2015: Solentim announced today it has been awarded ISO 9001:2008 Quality Management System (QMS) certification issued by ISOQAR, a UKAS accredited certification body. ISO 9001 is an internationally recognised certification of compliance reinforcing the commitment of Solentim to high quality policies, practices and procedures and their “right first time” attitude in the design and assembly of the Cell Metric™ cell line development equipment.

Commercial cell line development for the manufacturing of biologics and biosimilars is a high value process which is intrinsically expensive. As the go-to expert in this sector, ISO 9001 accreditation ensures a process of continual review and improvement by Solentim to meet the needs of a rapidly expanding global customer base. Equally it provides for enduring partnerships with key supply chain partners.

“Achieving ISO 9001 certification is another major step in the maturity and longevity of Solentim. It is also a pre-requisite for many of our customers, as large international public companies, for Solentim to become one of their approved suppliers. Certification is also a must-have for our international Distributors and their dealers when competing for public tender monies” commented Aaron Figg, Director at Solentim.

 

-- Ends --

 

About Solentim 
Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedicated to the development of innovative tools to shorten steps in the upstream cell line development workflow. The Cell Metric™ product range consists of bio-analytical imaging stations for rapid clone screening and documented proof of monoclonality for the FDA and other regulatory bodies. To find more information visit www.solentim.com

Commercial/ Media Enquiries:

Solentim Ltd
Dr Ian Taylor
T: +44-7554-446-185

E: [email protected]
W: www.solentim.com